Every successful company aims to expand and evolve, and one of the critical indicators of such growth is capital expenditure, commonly referred to as capex. Capital expenditure represents the funds invested by a company to enhance its operations, whether by increasing manufacturing capacity, introducing new products, or upgrading machinery. Let us explore the five companies that have made substantial capex investments in FY23 and are poised for promising growth in the coming years.

1. Clean Science and Technology – A Leap in Manufacturing Capacity
   Clean Science and Technology, a prominent chemical manufacturing company established in 2003, is a leader in producing critical speciality chemicals. The company operates across three manufacturing facilities with a total capacity of 44 million tonnes per annum (MTPA) and an impressive track record of growth. In FY23, Clean Science invested ₹1.9 billion in capex to expand its manufacturing capacity by 2,000 MTPA, introducing new products and enhancing its R&D efforts. The company’s commitment to funding its capex through internal cash accruals has helped it remain debt-free.
2. Aether Industries – Complex Chemistry for Promising Growth
   Aether Industries, another chemical manufacturing entity, focuses on intricate and differentiated chemistry, catering to speciality chemicals. With three manufacturing sites in India, the company invested ₹7.1 billion in capex to secure land for future manufacturing plants and expand existing facilities for new product lines. Funding its expansion through a Qualified Institutional Investors (QIP) initiative, Aether Industries stands ready to capitalize on the growing chemicals industry, leveraging its R&D capabilities and strategic alliances to drive significant revenue growth.
3. Gujarat Themis Biosyn – Nurturing Pharmaceuticals through Fermentation
   Gujarat Themis Biosyn manufactures and sells active pharmaceutical ingredients (API) via fermentation processes. With strategic investments totalling ₹440 million, the company constructed a warehouse and plans to allocate ₹2 billion for a fermentation block, API block, R&D lab, and more. The company’s prudent use of internal accruals to fund capex, coupled with its unique position in the fermentation process, positions it to achieve further revenue and net profit growth.
4. Devyani International – Embracing Evolution in the Food Industry
   Devyani International, a franchisee of Yum Brands and a major QSR operator in India has invested ₹28 billion in capex during FY23 to streamline and expand its business. The company plans to boost its store count and revenue by focusing on leaner models, delivery services, and small store formats. With a remarkable growth trajectory, Devyani International’s adaptation to changing consumer preferences and increased demand for fast food underline its potential for sustained growth.
5. Camlin Fine Sciences – Chemical Innovations for Tomorrow
   Camlin Fine Sciences, engaged in speciality chemical manufacturing, invested ₹6.8 billion in capex to improve its manufacturing capacity and introduce new products. Despite a temporary decline in net profit due to provisions, the company’s diversified businesses and expansion plans promise future growth. Its dedication to developing innovative products and refining manufacturing efficiency positions it well for success in the medium term.

Companies with high capital expenditure investments exhibit a positive outlook on growth and innovation. However, while such investments can lead to promising prospects, they should be assessed alongside a company’s financial health and funding sources. As you contemplate investing in these companies, diligent research into their fundamentals will provide insights into their growth potential and position in their respective industries.